These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 12171951)

  • 21. Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations?
    Frazzoni M; Manno M; De Micheli E; Savarino V
    Dig Liver Dis; 2006 Sep; 38(9):643-8. PubMed ID: 16627016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review article: prevalence of Barrett's oesophagus and metaplasia at the gastro-oesophageal junction.
    Sharma P
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():48-54; discussion 61-2. PubMed ID: 15456464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of Helicobacter pylori infection in 160 patients with Barrett's oesophagus or Barrett's adenocarcinoma.
    Lord RV; Frommer DJ; Inder S; Tran D; Ward RL
    Aust N Z J Surg; 2000 Jan; 70(1):26-33. PubMed ID: 10696939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Helicobacter pylori infection and the risk of Barrett's oesophagus: a community-based study.
    Corley DA; Kubo A; Levin TR; Block G; Habel L; Zhao W; Leighton P; Rumore G; Quesenberry C; Buffler P; Parsonnet J
    Gut; 2008 Jun; 57(6):727-33. PubMed ID: 17895354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Munich Barrett follow up study: suspicion of Barrett's oesophagus based on either endoscopy or histology only--what is the clinical significance?
    Meining A; Ott R; Becker I; Hahn S; Mühlen J; Werner M; Höfler H; Classen M; Heldwein W; Rösch T
    Gut; 2004 Oct; 53(10):1402-7. PubMed ID: 15361485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review: Barrett's oesophagus in Taiwan.
    Chen PH
    J Gastroenterol Hepatol; 1997 Jun; 12(6):S19-22. PubMed ID: 9195407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.
    Shapiro M; Green C; Faybush EM; Esquivel RF; Fass R
    Aliment Pharmacol Ther; 2006 Jan; 23(2):321-9. PubMed ID: 16393313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastro-oesophageal reflux: the disease of the millennium.
    Navaratnam RM; Winslet MC
    Hosp Med; 1998 Aug; 59(8):646-9. PubMed ID: 9829061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malignant Barrett's oesophagus.
    Li H
    Eur J Cancer Prev; 1993 Jan; 2(1):47-52. PubMed ID: 8428176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.
    Garside R; Pitt M; Somerville M; Stein K; Price A; Gilbert N
    Health Technol Assess; 2006 Mar; 10(8):1-142, iii-iv. PubMed ID: 16545207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High risk of malignancy in familial Barrett's esophagus: presentation of one family.
    Munitiz V; Parrilla P; Ortiz A; Martinez-de-Haro LF; Yelamos J; Molina J
    J Clin Gastroenterol; 2008 Aug; 42(7):806-9. PubMed ID: 18385604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familial aggregation of gastroesophageal reflux in patients with Barrett's esophagus and esophageal adenocarcinoma.
    Romero Y; Cameron AJ; Locke GR; Schaid DJ; Slezak JM; Branch CD; Melton LJ
    Gastroenterology; 1997 Nov; 113(5):1449-56. PubMed ID: 9352846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early adenocarcinoma of the oesophagus and oesophageal cyst.
    Santacroce CM; Fléjou JF
    Histopathology; 1997 Jul; 31(1):87-90. PubMed ID: 9253630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Daily use of non-steroidal anti-inflammatory drugs is less frequent in patients with Barrett's oesophagus who develop an oesophageal adenocarcinoma.
    Tsibouris P; Hendrickse MT; Isaacs PE
    Aliment Pharmacol Ther; 2004 Sep; 20(6):645-55. PubMed ID: 15352913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exercise and the Prevention of Oesophageal Cancer (EPOC) study protocol: a randomized controlled trial of exercise versus stretching in males with Barrett's oesophagus.
    Winzer BM; Paratz JD; Reeves MM; Whiteman DC
    BMC Cancer; 2010 Jun; 10():292. PubMed ID: 20550712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acid suppression and surgical therapy for Barrett's oesophagus.
    de Jonge PJ; Spaander MC; Bruno MJ; Kuipers EJ
    Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):139-50. PubMed ID: 25743462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The columnar-lined (Barrett's) oesophagus in black patients.
    Mason RJ; Bremner CG
    S Afr J Surg; 1998 May; 36(2):61-2. PubMed ID: 9711134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dietary factors and the risks of oesophageal adenocarcinoma and Barrett's oesophagus.
    Kubo A; Corley DA; Jensen CD; Kaur R
    Nutr Res Rev; 2010 Dec; 23(2):230-46. PubMed ID: 20624335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokeratin 7 and 20 expression in intestinal metaplasia of the distal oesophagus: relationship to gastro-oesophageal reflux disease.
    Shearer C; Going J; Neilson L; Mackay C; Stuart RC
    Histopathology; 2005 Sep; 47(3):268-75. PubMed ID: 16115227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of extra-oesophageal malignancies and colorectal cancer in Barrett's oesophagus and gastro-oesophageal reflux.
    Solaymani-Dodaran M; Logan RF; West J; Card T; Coupland C
    Scand J Gastroenterol; 2004 Jul; 39(7):680-5. PubMed ID: 15370691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.